Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1989 May;97(1):41–50. doi: 10.1111/j.1476-5381.1989.tb11921.x

The activation gate of the sodium channel controls blockade and deblockade by disopyramide in rabbit Purkinje fibres.

R Gruber 1, E Carmeliet 1
PMCID: PMC1854468  PMID: 2541858

Abstract

1. The effect of disopyramide on the maximum upstroke velocity (Vmax) and the sodium current of rabbit cardiac Purkinje fibres was studied with the two-microelectrode voltage-clamp technique. 2. In the absence of stimulation the drug did not cause block at membrane potentials ranging from -100 to -65 mV. Use-dependent block of Vmax was most pronounced at -75 mV. At hyperpolarized membrane potentials development of use-dependent block was faster than at depolarized membrane potentials. The time course of development of use-dependent block was not significantly influenced by the duration of the depolarizing pulse. These results strongly suggest that disopyramide predominantly blocks activated sodium channels. 3. The relative decrease of the sodium current at the beginning of a 2 s depolarizing clamp to -45 mV was almost the same as at the end, implying a rapid blockade of activated sodium channels. The Hill plots were linear with slopes ranging from 0.978 to 1.08 indicating a first order reaction; the dissociation constant for activated channels was 70 microM. 4. Recovery of Vmax from use-dependent block during rest was strongly voltage-dependent, the time constant of recovery increasing upon hyperpolarization. When the fraction of charged molecules was reduced by changing the pH of the external solution, the voltage-dependence of recovery was decreased. In contrast, recovery of Vmax for a change in holding potential from -80 to -95 mV was very fast during repetitive stimulation. 5. It is concluded that disopyramide blocks the sodium channel during activation and is trapped in the channel when the activation gate closes.

Full text

PDF
41

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bean B. P., Cohen C. J., Tsien R. W. Lidocaine block of cardiac sodium channels. J Gen Physiol. 1983 May;81(5):613–642. doi: 10.1085/jgp.81.5.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Carmeliet E. Activation block and trapping of penticainide, a disopyramide analogue, in the Na+ channel of rabbit cardiac Purkinje fibers. Circ Res. 1988 Jul;63(1):50–60. doi: 10.1161/01.res.63.1.50. [DOI] [PubMed] [Google Scholar]
  3. Carmeliet E. Slow inactivation of the sodium current in rabbit cardiac Purkinje fibres. Pflugers Arch. 1987 Jan;408(1):18–26. doi: 10.1007/BF00581835. [DOI] [PubMed] [Google Scholar]
  4. Carmeliet E. Slowly developing activation block of cardiac sodium channels by a lidocaine analog, transcainide. J Cardiovasc Pharmacol. 1988 Jul;12(1):110–115. doi: 10.1097/00005344-198807000-00015. [DOI] [PubMed] [Google Scholar]
  5. Carmeliet E. Voltage-dependent block by tetrodotoxin of the sodium channel in rabbit cardiac Purkinje fibers. Biophys J. 1987 Jan;51(1):109–114. doi: 10.1016/S0006-3495(87)83315-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cohen C. J., Bean B. P., Tsien R. W. Maximal upstroke velocity as an index of available sodium conductance. Comparison of maximal upstroke velocity and voltage clamp measurements of sodium current in rabbit Purkinje fibers. Circ Res. 1984 Jun;54(6):636–651. doi: 10.1161/01.res.54.6.636. [DOI] [PubMed] [Google Scholar]
  7. Courtney K. R. Structure-activity relations for frequency-dependent sodium channel block in nerve by local anesthetics. J Pharmacol Exp Ther. 1980 Apr;213(1):114–119. [PubMed] [Google Scholar]
  8. Hille B. Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol. 1977 Apr;69(4):497–515. doi: 10.1085/jgp.69.4.497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hille B. The pH-dependent rate of action of local anesthetics on the node of Ranvier. J Gen Physiol. 1977 Apr;69(4):475–496. doi: 10.1085/jgp.69.4.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hondeghem L. M., Katzung B. G. Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs. Annu Rev Pharmacol Toxicol. 1984;24:387–423. doi: 10.1146/annurev.pa.24.040184.002131. [DOI] [PubMed] [Google Scholar]
  11. Hondeghem L. M., Katzung B. G. Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta. 1977 Nov 14;472(3-4):373–398. doi: 10.1016/0304-4157(77)90003-x. [DOI] [PubMed] [Google Scholar]
  12. Kojima M., Ban T., Sada H. Effects of disopyramide on the maximum rate of rise of action potential (Vmax) in guinea-pig papillary muscles. Jpn J Pharmacol. 1982 Feb;32(1):91–102. doi: 10.1254/jjp.32.91. [DOI] [PubMed] [Google Scholar]
  13. Kus T., Sasyniuk B. I. Disopyramide phosphate: is it just another quinidine. Can J Physiol Pharmacol. 1978 Apr;56(2):326–331. doi: 10.1139/y78-049. [DOI] [PubMed] [Google Scholar]
  14. Saikawa T., Carmeliet E. Slow recovery of the maximal rate of rise (Vmax) of the action potential in sheep cardiac Purkinje fibers. Pflugers Arch. 1982 Jul;394(1):90–93. doi: 10.1007/BF01108313. [DOI] [PubMed] [Google Scholar]
  15. Schwarz W., Palade P. T., Hille B. Local anesthetics. Effect of pH on use-dependent block of sodium channels in frog muscle. Biophys J. 1977 Dec;20(3):343–368. doi: 10.1016/S0006-3495(77)85554-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Starmer C. F., Courtney K. R. Modeling ion channel blockade at guarded binding sites: application to tertiary drugs. Am J Physiol. 1986 Oct;251(4 Pt 2):H848–H856. doi: 10.1152/ajpheart.1986.251.4.H848. [DOI] [PubMed] [Google Scholar]
  17. Starmer C. F., Grant A. O., Strauss H. C. Mechanisms of use-dependent block of sodium channels in excitable membranes by local anesthetics. Biophys J. 1984 Jul;46(1):15–27. doi: 10.1016/S0006-3495(84)83994-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Starmer C. F., Yeh J. Z., Tanguy J. A quantitative description of QX222 blockade of sodium channels in squid axons. Biophys J. 1986 Apr;49(4):913–920. doi: 10.1016/S0006-3495(86)83719-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Strichartz G. R. The inhibition of sodium currents in myelinated nerve by quaternary derivatives of lidocaine. J Gen Physiol. 1973 Jul;62(1):37–57. doi: 10.1085/jgp.62.1.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Strichartz G., Cohen I. Vmax as a measure of GNa in nerve and cardiac membranes. Biophys J. 1978 Jul;23(1):153–156. doi: 10.1016/S0006-3495(78)85440-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Weld F. M., Coromilas J., Rottman J. N., Bigger J. T., Jr Mechanisms of quinidine-induced depression of maximum upstroke velocity in ovine cardiac Purkinje fibers. Circ Res. 1982 Mar;50(3):369–376. doi: 10.1161/01.res.50.3.369. [DOI] [PubMed] [Google Scholar]
  22. Yeh J. Z. Dynamics of 9-aminoacridine block of sodium channels in squid axons. J Gen Physiol. 1979 Jan;73(1):1–21. doi: 10.1085/jgp.73.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Yeh J. Z., Tanguy J. Na channel activation gate modulates slow recovery from use-dependent block by local anesthetics in squid giant axons. Biophys J. 1985 May;47(5):685–694. doi: 10.1016/S0006-3495(85)83965-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Yeh J. Z., TenEick R. E. Molecular and structural basis of resting and use-dependent block of sodium current defined using disopyramide analogues. Biophys J. 1987 Jan;51(1):123–135. doi: 10.1016/S0006-3495(87)83317-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES